Achieve Life Sciences, Inc. (ACHV) |
| 3.61 0.03 (0.84%) 04-14 16:00 |
| Open: | 3.645 |
| High: | 3.725 |
| Low: | 3.59 |
| Volume: | 513,827 |
| Market Cap: | 192(M) |
| PE Ratio: | -2.89 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 5.14 |
| Resistance 1: | 4.40 |
| Pivot price: | 3.13 |
| Support 1: | 3.30 |
| Support 2: | 2.62 |
| 52w High: | 6.03 |
| 52w Low: | 1.95 |
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
| EPS | -1.250 |
| Book Value | 0.400 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -85.3 |
| Return on Equity (ttm) | -257.7 |
Wed, 01 Apr 2026
Achieve Life Sciences: The Recent Sell-Off Skews The Outcomes (NASDAQ:ACHV) - Seeking Alpha
Tue, 24 Mar 2026
Achieve Life Sciences (NASDAQ: ACHV) deepens 2025 loss while eyeing 2026 FDA decision - Stock Titan
Tue, 24 Mar 2026
Achieve Life Sciences (NASDAQ:ACHV) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Tue, 24 Mar 2026
ACHIEVE LIFE SCIENCES ($ACHV) Releases Q4 2025 Earnings | ACHV Stock News - Quiver Quantitative
Tue, 24 Mar 2026
Earnings call transcript: Achieve Life Sciences Q4 2025 reports stable EPS, stock dips - Investing.com
Tue, 24 Mar 2026
Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - GlobeNewswire
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |